Edgardo S. Santos Castillero, MD, FACP, Florida Precision Oncology
Advertisement
Articles by Edgardo S. Santos Castillero, MD, FACP, Florida Precision Oncology
Advertisement
Latest Updated Articles
Metastatic NSCLC: The Role of Liquid BiopsyPublished: September 29th 2020 | Updated:
EGFR TKI Plus Chemotherapy Combination StrategyPublished: September 29th 2020 | Updated:
TKI Combination Clinical Trials: Practical Implications in US and UKPublished: September 29th 2020 | Updated:
EGFR-Mutated NSCLC: Looking AheadPublished: September 29th 2020 | Updated:
Approved Frontline TKIs for EGFR-Mutated DiseasePublished: September 29th 2020 | Updated:
Molecular Testing in Metastatic NSCLCPublished: September 29th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5